Chapter 6 - THE CFO WHO SAID THERE WAS NOTHING TO SEEWarren Pike had worked for Halcyon for nine years.

Grant trusted him because Claire had.
That mattered more than he admitted.
Claire died four years earlier after a long battle with leukemia.
She had inherited Halcyon shares from her father.
After her death, those shares went into trust for Mason.
Grant became trustee.
Warren became the person who helped him navigate a company he never wanted to control.
Grant’s own career was in commercial real estate.
Biotech might as well have been another language.
Warren translated.
Board votes.
Dividend structures.
Regulatory disclosures.
Clinical partnerships.
Grant relied on him.
Now security footage showed Warren leaving Rourke’s office with Eleanor.
Grant called him.
No answer.
Again.
Voicemail.
Third time.
Warren picked up.
“Grant.”
“Where are you?”
“At home.”
“Come to St. Alden.”
Pause.
“Why?”
Grant almost laughed.
“You know why.”
Silence.
Then Warren sighed.
“I told Malcolm this was reckless.”
Grant’s entire body went cold.
“Come here.”
“Grant—”
“Now.”
Warren arrived forty minutes later with an attorney.
That told Grant everything.
They met in a hospital conference room.
Charles present.
Lydia on video.
Hospital counsel.
Warren looked at Grant but not for long.
Grant placed a still image on the table.
“You.”
Warren nodded.
“Eleanor.”
“Yes.”
“Rourke.”
“Yes.”
“What were you discussing?”
Warren’s lawyer started.
“We are not—”
Warren raised a hand.
“The merger.”
Grant stared.
“Why does Eleanor care?”
Warren looked tired.
“Because she thinks Claire’s shares should never leave the family.”
“She doesn’t own them.”
“I know.”
“Then what?”
“She wanted Mason’s block voted against the sale.”
“Why?”
“Partly emotion.”
“Partly?”
Warren looked at his lawyer.
Then continued.
“Money.”
Grant leaned forward.
“How much?”
Warren hesitated.
“Eleanor borrowed from Rourke.”
“How much?”
“Two point four million.”
Grant’s jaw tightened.
“For what?”
“An investment.”
“What investment?”
“A senior-living development outside Providence.”
Grant knew Eleanor had bragged about that project two years earlier.
She claimed to be an adviser.
Not investor.
“It failed?”
“Yes.”
“Rourke funded her.”
“Yes.”
“Personal loan?”
“Through an entity.”
“And now she owes him.”
“Yes.”
Grant looked at Warren.
“What do you owe him?”
Warren went pale.
There.
Grant saw it.
“Say it.”
“Nothing personally.”
“Then why were you in his office?”
Warren looked down.
“Because I hid information.”
Grant felt cold.
“What information?”
“The Creston contracts.”
Rourke’s undisclosed financial interest.
Warren discovered it during merger preparation months ago.
He should have reported it.
Instead, Rourke convinced him the payments were technically legal consulting income.
“Were they?”
“No.”
“Why hide it?”
Warren swallowed.
“Because I approved two later amendments.”
Grant stared.
“You signed them.”
“Yes.”
“Knowing Rourke had a conflict?”
“Not initially.”
“Later?”
“Yes.”
“And you kept quiet.”
“Yes.”
If the merger due diligence exposed the contracts, Warren’s career ended.
Possibly worse.
Three adults.
Three motives.
Eleanor’s debt.
Rourke’s hidden profits.
Warren’s concealment.
And Mason’s shares were the obstacle.
Grant asked:
“Who came up with removing me as trustee?”
Warren did not answer.
“Warren.”
“Eleanor.”
Grant closed his eyes.
Of course.
“She knew the trust language.”
“Yes.”
“How?”
“She had an old copy.”
“Why would Rourke help?”
“To stop the vote.”
“And you?”
Warren looked ashamed.
“I told them it was insane.”
“But you stayed.”
“Yes.”
“What did you do?”
“Nothing with Mason.”
Grant stood.
“That isn’t what I asked.”
Warren flinched.
“I supplied the merger timeline.”
“You told them exactly when they needed control.”
“Yes.”
“Did you help draft the petition?”
“No.”
“Did you know Rourke was falsifying medical records?”
“No.”
Grant stared.
“Did you know Eleanor planned to use Mason’s hospitalization?”
“I knew she said an opportunity had appeared.”
That answer was enough.
“You knew a sick eleven-year-old had become an opportunity.”
Warren closed his eyes.
“Yes.”
Silence.
Grant looked away.
The room blurred for a moment.
Claire trusted this man.
He had sat at her memorial.
Sent Mason birthday gifts.
Helped Grant understand the trust.
And when preserving his career required silence, he chose silence.
Grant asked:
“Who changed the chart?”
Warren shook his head.
“I don’t know.”
“Who gave Eleanor the pill?”
“I don’t know.”
“Who disabled the camera?”
“Rourke, I assume.”
“Assume?”
“He said he could control the hospital side.”
Grant felt nausea.
The hospital side.
As though Mason’s room were simply another workstream.
Warren’s lawyer intervened.
The meeting ended.
But before leaving, Warren said:
“Grant.”
He turned.
“There’s something Eleanor doesn’t know.”
Grant waited.
“Rourke isn’t only trying to stop the merger.”
“What else?”
Warren swallowed.
“The buyer’s audit found something bigger than Creston.”
“How big?”
“Clinical data.”
Grant stared.
“What clinical data?”
“One of Halcyon’s old pediatric monitoring devices.”
His pulse changed.
Warren continued.
“There were adverse-event reports that never reached the board.”
Grant went still.
“Children?”
Warren looked down.
“Yes.”
The conspiracy had just changed shape.
Rourke was not merely protecting money.
May you like
He might be protecting evidence that medical problems involving children had been hidden.
And the sick child he was now willing to use was Mason.
Related Stories